Overall rank by patents
#24,921
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 20 technology areas, active 2017–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B60B (VEHICLE WHEELS ; CASTORS; AXLES FOR WHEELS OR CASTORS; INCREASING WHEEL ADHESION).
The verdict
Orbis holds 11 US patents across 20 technology areas, rank #24,921 of 50,000 tracked assignees.
Orbis Wheels, Inc. has been granted 11 US utility patents between 2017 and 2020, placing Orbis Wheels, Inc. at rank #24,921 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.6 claims per patent with primary concentration in B60B (VEHICLE WHEELS ; CASTORS; AXLES FOR WHEELS OR CASTORS; INCREASING WHEEL ADHESION). As a US Corporation, Orbis Wheels, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Orbis sits between OMNI LPS. Co., Ltd. (11 patents, rank #24,917) and Ossium Health, Inc. (11 patents, rank #24,925) - the closest US assignees by grant volume. The composite Innovation Score of 34.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 10 in the 2015–2019 window, a -90% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Orbis Wheels, Inc.'s 17.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Orbis Wheels, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
OMNI LPS. CO., LTD.
11 patents
ONKOS SURGICAL, INC.
11 patents
OPTOMAK, INC.
11 patents
ORASURE TECHNOLOGIES, INC.
11 patents
ORGANOCLICK AB
11 patents
ORTA DOGU TEKNIK UNIVERSITESI
11 patents
OSONG MEDICAL INNOVATION FOUNDATION
11 patents
OSSIUM HEALTH, INC.
11 patents
ORBIS WHEELS, INC.
11 patents
What this shows Orbis holds 11 patents at rank #24,921, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Orbis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 51% higher than 49% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 3 | 27.3% |
| 2018 | 5 | 45.5% |
| 2019 | 2 | 18.2% |
| 2020 | 1 | 9.1% |
Top 15 of 20 technology areas
Overall rank by patents
#24,921
Across all tracked assignees
34.9 out of 100
How to use this portfolio
Orbis's 11 grants land it in the top 51% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.